These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 23498719)

  • 1. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.
    Rushlow DE; Mol BM; Kennett JY; Yee S; Pajovic S; Thériault BL; Prigoda-Lee NL; Spencer C; Dimaras H; Corson TW; Pang R; Massey C; Godbout R; Jiang Z; Zacksenhaus E; Paton K; Moll AC; Houdayer C; Raizis A; Halliday W; Lam WL; Boutros PC; Lohmann D; Dorsman JC; Gallie BL
    Lancet Oncol; 2013 Apr; 14(4):327-34. PubMed ID: 23498719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
    Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
    Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RB1 gene inactivation by chromothripsis in human retinoblastoma.
    McEvoy J; Nagahawatte P; Finkelstein D; Richards-Yutz J; Valentine M; Ma J; Mullighan C; Song G; Chen X; Wilson M; Brennan R; Pounds S; Becksfort J; Huether R; Lu C; Fulton RS; Fulton LL; Hong X; Dooling DJ; Ochoa K; Mardis ER; Wilson RK; Easton J; Zhang J; Downing JR; Ganguly A; Dyer MA
    Oncotarget; 2014 Jan; 5(2):438-50. PubMed ID: 24509483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma.
    Dimaras H; Khetan V; Halliday W; Orlic M; Prigoda NL; Piovesan B; Marrano P; Corson TW; Eagle RC; Squire JA; Gallie BL
    Hum Mol Genet; 2008 May; 17(10):1363-72. PubMed ID: 18211953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression.
    Kooi IE; Mol BM; Moll AC; van der Valk P; de Jong MC; de Graaf P; van Mil SE; Schouten-van Meeteren AY; Meijers-Heijboer H; Kaspers GL; Te Riele H; Cloos J; Dorsman JC
    EBioMedicine; 2015 Jul; 2(7):660-70. PubMed ID: 26288838
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Price EA; Patel R; Scheimberg I; Kotiloglu Karaa E; Sagoo MS; Reddy MA; Onadim Z
    Ophthalmic Genet; 2021 Oct; 42(5):604-611. PubMed ID: 34003079
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomic differences between retinoma and retinoblastoma.
    Sampieri K; Mencarelli MA; Epistolato MC; Toti P; Lazzi S; Bruttini M; De Francesco S; Longo I; Meloni I; Mari F; Acquaviva A; Hadjistilianou T; Renieri A; Ariani F
    Acta Oncol; 2008; 47(8):1483-92. PubMed ID: 18785023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rb suppresses human cone-precursor-derived retinoblastoma tumours.
    Xu XL; Singh HP; Wang L; Qi DL; Poulos BK; Abramson DH; Jhanwar SC; Cobrinik D
    Nature; 2014 Oct; 514(7522):385-8. PubMed ID: 25252974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
    Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
    Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI Features for Identifying
    Jansen RW; de Bloeme CM; Cardoen L; Göricke S; van Elst S; Jessen JL; Ramasubramanian A; Skalet AH; Miller AK; Maeder P; Uner OE; Hubbard GB; Grossniklaus H; Boldt HC; Nichols KE; Brennan RC; Sen S; Sirin S; Brisse HJ; Galluzzi P; Dommering CJ; Castelijns JA; van der Valk P; Boellaard R; Dorsman J; Moll AC; de Jong MC; de Graaf P
    Radiology; 2023 Jun; 307(5):e222264. PubMed ID: 37191489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families.
    Li WL; Buckley J; Sanchez-Lara PA; Maglinte DT; Viduetsky L; Tatarinova TV; Aparicio JG; Kim JW; Au M; Ostrow D; Lee TC; O'Gorman M; Judkins A; Cobrinik D; Triche TJ
    J Mol Diagn; 2016 Jul; 18(4):480-93. PubMed ID: 27155049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Level
    Roohollahi K; de Jong Y; van Mil SE; Fabius AWM; Moll AC; Dorsman JC
    Ophthalmol Sci; 2022 Sep; 2(3):100188. PubMed ID: 36245757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary enucleated retinoblastoma with MYCN amplification.
    Moulin AP; Stathopoulos C; Marcelli F; Schoumans Pouw J; Beck-Popovic M; Munier FL
    Ophthalmic Genet; 2021 Jun; 42(3):354-359. PubMed ID: 33870828
    [No Abstract]   [Full Text] [Related]  

  • 14. A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence.
    Wu N; Jia D; Bates B; Basom R; Eberhart CG; MacPherson D
    J Clin Invest; 2017 Mar; 127(3):888-898. PubMed ID: 28165337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour.
    Zhang H; Konjusha D; Rafati N; Tararuk T; Hallböök F
    Cell Oncol (Dordr); 2024 Feb; 47(1):209-227. PubMed ID: 37606819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MYCN in retinoblastoma: A review of current literature.
    Vempuluru VS; Maniar A; Bakal K; Kaliki S
    Surv Ophthalmol; 2024; 69(5):697-706. PubMed ID: 38796108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and Molecular Diagnostics in Retinoblastoma--An Update.
    Soliman SE; Racher H; Zhang C; MacDonald H; Gallie BL
    Asia Pac J Ophthalmol (Phila); 2017; 6(2):197-207. PubMed ID: 28399338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How does MYCN amplification make neuroblastomas behave aggressively? Still more questions than answers.
    Maris JM
    Pediatr Blood Cancer; 2005 Dec; 45(7):869-70. PubMed ID: 16206200
    [No Abstract]   [Full Text] [Related]  

  • 19. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
    Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
    Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1.
    Bowles E; Corson TW; Bayani J; Squire JA; Wong N; Lai PB; Gallie BL
    Genes Chromosomes Cancer; 2007 Feb; 46(2):118-29. PubMed ID: 17099872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.